CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $408,934 | -59.3% | 13,881 | -55.0% | 0.00% | -66.7% |
| Q2 2023 | $1,005,249 | +4.1% | 30,817 | +12.3% | 0.01% | 0.0% |
| Q1 2023 | $965,402 | -62.9% | 27,434 | -51.8% | 0.01% | -59.1% |
| Q4 2022 | $2,605,371 | -16.4% | 56,861 | -28.4% | 0.02% | -26.7% |
| Q2 2022 | $3,118,000 | +932.5% | 79,366 | +867.9% | 0.03% | +900.0% |
| Q1 2022 | $302,000 | -93.5% | 8,200 | -91.9% | 0.00% | -92.9% |
| Q4 2021 | $4,635,000 | +63.1% | 101,700 | +27.9% | 0.04% | +44.8% |
| Q3 2021 | $2,841,000 | +606.7% | 79,516 | +291.7% | 0.03% | +625.0% |
| Q2 2021 | $402,000 | +157.7% | 20,300 | +53.1% | 0.00% | -60.0% |
| Q1 2020 | $156,000 | -15.2% | 13,263 | -33.7% | 0.01% | -67.7% |
| Q3 2016 | $184,000 | – | 20,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |